NVO FY 2012 Earnings Report — Novo Nordisk A/S Revenue & Financial Results | Market Cap Arena

Novo Nordisk A/SNVO

FY 2012 Earnings

Reported December 30, 2012

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2012	Prior Q	FY 2011	QoQ Change	YoY Change
Revenue	$12.2B	—	$10.4B	—	17.6%
Op. Income	$4.6B	—	$3.5B	—	31.7%
Gross Margin	82.7%	—	81.0%	—	1.7pp
Net Margin	27.5%	—	25.8%	—	1.7pp
EPS (Diluted)	$0.61	—	$0.47	—	29.7%
Free Cash Flow	$2.9B	—	$2.8B	—	3.0%

Revenue Flow

Item	Amount
REVENUE	$12.2B
Cost of Revenue	$2.1B
GROSS PROFIT	$10.1B
R&D Expenses	$1.7B
Selling & Marketing	$3.4B
General & Administrative	$520M
SG&A Expenses	$3.9B
Other Expenses	-$105M
Operating Expenses	$5.5B
Cost & Expenses	$7.6B
OPERATING INCOME	$4.6B
Interest Income	$19M
Interest Expense	$9M
Other Income/Expenses	-$261M
INCOME BEFORE TAX	$4.4B
Income Tax Expense	$1.0B
Net Income from Continuing Ops	$3.4B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$3.4B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$3.4B
D&A	$423M
EBIT	$4.4B
EBITDA	$4.8B
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$12.2B
Cost of Revenue	$2.1B
GROSS PROFIT	$10.1B
R&D Expenses	$1.7B
Selling & Marketing	$3.4B
General & Administrative	$520M
SG&A Expenses	$3.9B
Other Expenses	-$105M
Operating Expenses	$5.5B
Cost & Expenses	$7.6B
OPERATING INCOME	$4.6B
Interest Income	$19M
Interest Expense	$9M
Other Income/Expenses	-$261M
INCOME BEFORE TAX	$4.4B
Income Tax Expense	$1.0B
Net Income from Continuing Ops	$3.4B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$3.4B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$3.4B
D&A	$423M
EBIT	$4.4B
EBITDA	$4.8B
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$3.4B
Depreciation & Amortization	$423M
Stock-Based Compensation	$48M
Deferred Income Tax	$1.0B
Other Non-Cash Items	-$1.4B
Change in Working Capital	$43M
OPERATING CASH FLOW	$3.5B
Capital Expenditure	-$568M
Acquisitions (Net)	$0
Purchases of Investments	-$79M
Sales/Maturities of Investments	$0
Other Investing Activities	$8M
NET CASH FROM INVESTING	-$639M
Net Debt Issuance	-$79M
Common Stock Repurchased	-$1.9B
Common Dividends Paid	-$1.2B
Other Financing Activities	$0
NET CASH FROM FINANCING	-$3.2B
FREE CASH FLOW	$2.9B
Net Change in Cash	-$314M

Balance Sheet

Item	Amount
Cash & Equivalents	$1.8B
Short-Term Investments	$714M
Net Receivables	$2.0B
Inventory	$1.5B
Other Current Assets	$683M
TOTAL CURRENT ASSETS	$6.3B
PP&E (Net)	$3.4B
Goodwill	$0
Intangible Assets	$235M
Long-Term Investments	$36M
Tax Assets	$352M
Other Non-Current Assets	$0
TOTAL NON-CURRENT ASSETS	$4.0B
TOTAL ASSETS	$10.3B
Account Payables	$606M
Short-Term Debt	$78M
Deferred Revenue	$2.7B
Other Current Liabilities	$1.9B
TOTAL CURRENT LIABILITIES	$3.4B
Long-Term Debt	$0
Deferred Revenue NC	$0
Deferred Tax Liabilities	$115M
Other Non-Current Liabilities	$418M
TOTAL NON-CURRENT LIABILITIES	$533M
TOTAL LIABILITIES	$3.9B
Common Stock	$88M
Additional Paid-In Capital	$88M
Retained Earnings	$6.1B
Treasury Stock	-$3M
Accum. Other Comp. Income	$171M
Other Equity	-$88M
TOTAL STOCKHOLDERS' EQUITY	$6.4B
Minority Interest	$0
TOTAL EQUITY	$6.4B
TOTAL LIABILITIES & EQUITY	$10.3B
Total Debt	$78M
Net Debt	-$1.7B